Grek, C. L., Sheng, Z., Naus, C. C., Sin, W. C., Gourdie, R. G., & Ghatnekar, G. G. (2018). Novel approach to temozolomide resistance in malignant glioma: Connexin43-directed therapeutics. Curr Opin Pharmacol.
Chicago Style aipamenaGrek, Christina L., Zhi Sheng, Christian C. Naus, Wun Chey Sin, Robert G. Gourdie, and Gautam G. Ghatnekar. "Novel Approach to Temozolomide Resistance in Malignant Glioma: Connexin43-directed Therapeutics." Curr Opin Pharmacol 2018.
MLA aipamenaGrek, Christina L., et al. "Novel Approach to Temozolomide Resistance in Malignant Glioma: Connexin43-directed Therapeutics." Curr Opin Pharmacol 2018.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.